Biora Therapeutics, Inc.
TREATMENT OF INFLAMMATORY DISEASE USING INGESTIBLE DEVICE TO RELEASE IMMUNE MODULATOR
Last updated:
Abstract:
This disclosure features methods and compositions for treating inflammatory disorders or conditions that arise in a tissue originating from the endoderm using an immune modulator.
Status:
Application
Type:
Utility
Filling date:
13 Aug 2018
Issue date:
15 Oct 2020